Roche has returned the rights to UCB’s anti-tau antibody bepranemab, walking away from a $120 million bet on the Alzheimer’s ...
UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...
Yale spinout Modifi agreed to sell to Merck for $30 million upfront. Elsewhere, Sangamo plotted a much faster path to market ...
GREENVILLE, S.C. , Oct. 23, 2024 (GLOBE NEWSWIRE) -- United Community Banks, Inc. (NYSE: UCB) (United) today announced net income for the 2024 third quarter of $47.3 million and pre-tax, ...
October 17, 2024, 13:48 pm ET, BY Jolene W.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Short UCB slightly ...